Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Syandana Taila: The drug shall be administrated locally in the form of Taila 2ml (for external use only) in Fistula-in-ano.
Control Intervention1: Povidone-iodine solution: This drug sh
Sponsors
STATE AYURVEDIC COLLEGE AND HOSPITAL LUCKNOW
Eligibility
Inclusion criteria
Inclusion criteria: All patients having signs & symptoms of Bhagandara (fistula-in-ano) and complain of pain, swelling and pus discharge through an opening.
Exclusion criteria
Exclusion criteria: 1. Patients suffering from acute infectious disease, malignancy and chronic infectious disease. 2. Patients having congenital anomalies. 3. Patients having age less than 18 yrs & more than 65 yrs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To assess the efficacy of Syandana Taila in the management of Fistula-in-Ano. 2. To assess the efficacy of trial drug on subjective parameters like pain itching discharge.Timepoint: 1. To assess the efficacy of Syandana Taila in the management of Fistula-in-Ano. 2. To assess the efficacy of trial drug on subjective parameters like pain itching discharge in 2 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the efficacy of Syandana Taila in the management of Fistula-in-Ano. 2. To assess the efficacy of trial drug on subjective parameters like pain itching discharge.Timepoint: for 2 to 4 month | — |
Countries
India
Contacts
Public ContactDR RAJEEV NARAYAN BILAS
STATE AYURVEDIC COLLEGE & HOSPITAL LUCKNOW
Outcome results
None listed